Cambio - Excellence in Molecular Biology

Search
Competent Cells

Competent Cells: IG® Ultra-High Efficiency Electrocompetent E. coli Cells

IG® Ultra-High Efficiency Electrocompetent E. coli Cells

 

Intact Genomics (IG®, ig®) offers the largest collections of high-quality competent cells on the market.

Originally founded as a BAC cloning company, Intact Genomics developed deep expertise in producing ultra-high-efficiency competent cells to enable transformation of very large plasmids (~300 kb) into E. coli. Over the years, this expertise—combined with continuous process optimization—has allowed us to consistently deliver exceptionally high transformation efficiencies and reliable performance.

Combining our scientists’ expertise and craftsmanship with state-of-the-art equipment, advanced protocols, and rigorous quality control standards, our competent cells provide the following advantages:

  • Exceptional Transformation Efficiency – Up to 10–100× higher than other leading brands.
  • Consistent Quality – Manufactured under an ISO 13485:2016-certified quality management system to ensure reliable lot-to-lot performance.
  • Competitive Pricing– High-performance products at affordable prices to help maximize your research budget.
  • Flexible Formats and Custom Services – We offer a broader range of formats than competitors, including tubes (multiple aliquot sizes), 96- and 384-well plates, and strip tubes. We also provide custom competent cell services tailored to your specific needs.

Application

Product 

Specialization

Efficiency

Routine Cloning

ig® 5-alpha Electrocompetent Cells

Routine cloning and sub-cloning, library construction (DNA <10 kb)

≥2.0 × 1010

ig® 10B Electrocompetent Cells

Routine cloning and sub-cloning, library preparation including large DNA >10 kb

≥5.0 × 1010

ig® XL1 Blue Max Electrocompetent Cells

Stable plasmid propagation with blue/white screening

≥5.0 × 1010

HB101 Electrocompetent Cells

Stable plasmid maintenance

≥5.0 × 1010

Specialized Cloning

igMax™ DH10B Electrocompetent Cells

Difficult large DNA fragment cloning, BAC library construction

≥5.0 × 1010

IG® Recombineering Electrocompetent Cells

Homologous recombination, DNA, plasmid, and BAC engineering

≥1.0 × 1010

ig® Stable 2 Electrocompetent E. coli Cells

Cloning direct repeat sequences (unstable DNA)

≥2.0 × 109

ig® ccdB Resist™ Electrocompetent E. coli Cells

Propagation of plasmids containing the ccdB gene

≥1.0 × 1010

Staphylococcus aureus (S. aureus) RN4220 ElectroCompetent Cells

A gateway strain to enable DNA manipulation in Staphylococcus aureus

≥1 × 105

Protein Expression

IG® Autoinduction DE3 ElectroCompetent Cells

Optimized for autoinduction of protein expression

≥1.0 × 1010

BL21(DE3) Electrocompetent Cells

Routine T7 protein expression

≥1.0 × 1010

BL21(DE3)pLysS ElectroCompetent Cells

Routine non-T7 protein expression

≥1.0 × 1010

IG® C41(DE3) Electrocompetent Cells

Improved expression of toxic proteins

≥1.0 × 1010

IG® C41(DE3)pLysS Electrocompetent Cells

Improved expression of toxic proteins with suppressed basal expression

≥1.0 × 109

IG® C43(DE3) Electrocompetent Cells

Most tolerant of toxic proteins

≥1.0 × 1010

IG® C43(DE3)pLysS Electrocompetent Cells

Most tolerant of toxic proteins with suppressed basal expression

≥5.0 × 109

Phage Display

TG1 Phage Display Electrocompetent Cells

Antibody phage display with amber suppressor

≥4.0 × 1010

SS320 Phage Display Electrocompetent Cells

Antibody phage display

≥5.0 × 1010

ER2738 Phage Display ElectroCompetent Cells

Peptide phage display with amber suppressor

≥4.0 × 1010

Medium

IG® Recovery Medium

Superior formulation for all competent cell transformations

High-efficiency

IG® Autoinduction Medium

Promotes high-yield growth of E. coli and high-level expression of T7 promoter-regulated recombinant proteins

High-efficiency

 

Custom Formats, Custom Package Sizes and Bulk Pricing Are Available Upon Request

 

IG C41(DE3) Electrocompetent Cells

Struggling to express toxic or difficult proteins? Intact Genomics (IG®) C41(DE3) Electocompetent Cells are engineered to improve tolerance to toxic protein expression while maintaining reliable T7-driven performance. Derived from BL21(DE3), C41(DE3) strain reduces cell death associated with membrane proteins, nucleases, and other challenging targets. When standard BL21(DE3) fails, C41(DE3) helps move your project forward. Custom formats, custom package sizes and bulk pricing are available upon request.

Intact Genomics

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
IG-1243-12IG C41(DE3) Electrocompetent Cells6x50µl £313.00 Quantity
Add
IG-1243-12IG C41(DE3) Electrocompetent Cells6x50µl £751.00 Quantity
Add
IG-1243-48IG C41(DE3) Electrocompetent Cells24x50µl £751.00 Quantity
Add

IG C41(DE3) Electrocompetent Cells

 

Struggling to express toxic or difficult proteins? Intact Genomics (IG®) C41(DE3) Electocompetent Cells are engineered to improve tolerance to toxic protein expression while maintaining reliable T7-driven performance. Derived from BL21(DE3), C41(DE3) strain reduces cell death associated with membrane proteins, nucleases, and other challenging targets. When standard BL21(DE3) fails, C41(DE3) helps move your project forward.

Custom formats, custom package sizes and bulk pricing are available upon request.

 

Product Description

Intact Genomics (IG®) C41(DE3) Electrocompetent Cells are designed for transformation and routine recombinant protein expression from vectors under an IPTG-inducible T7 promoter. The C41(DE3) strain is a BL21(DE3) mutant originally selected as survivor cells overexpressing the toxic oxoglutarate-malate carrier protein (OGCP). It carries lacI and additional mutations that help prevent cell death associated with the expression of many toxic recombinant proteins.

IG® C41(DE3) Electrocompetent Cells enable efficient expression of toxic proteins from a wide range of organisms, including viruses, bacteria, yeasts, plants, animals, and mammals. The effectiveness of the C41(DE3) strain for expressing toxic proteins has been demonstrated in a patent and validated in more than 400 publications.

 

Specifications:

Competent cell type: Electro competent
Species: E. coli
Strain: C41(DE3)
Format: Tubes
Transformation efficiency: ≥ 1.0 x 1010 cfu/µg pUC19 DNA
Blue/white screening: No
Shipping condition: Dry ice

 

Reagents Needed for One Reaction

IG® C41(DE3) Electrocompetent cells: 25 µl
DNA (or pUC19 Control, 10 pg/µl): 1 µl
Recovery medium: 1 ml

 

Product Components and Recommended Storage Condition:

  • IG® C41(DE3) Electrocompetent Cells: -80°C
  • DNA (pUC19, 10 pg/µl): -20°C
  • Recovery medium: 4°C

 

Genomic Features:

IG® C41(DE3) Electrocompetent Cells have the following features:

  • T7 Expression Strain
  • Selected for expression of toxic proteins
  • Suitable for expression of toxic genes

 

Quality Control:

Transformation efficiency is tested by using the pUC19 control DNA supplied with the kit and the high efficiency transformation protocol listed below. Transformation efficiency should be ≥ 1.0 x 1010 CFU/µg pUC19 DNA.

Untransformed cells are tested for appropriate antibiotic sensitivity.

 

General Guidelines:
Follow these guidelines when using IG C41(DE3) Electrocompetent Cells.

  • Handle competent cells gently as they are highly sensitive to changes in temperature or mechanical lysis caused by pipetting.
  • Thaw competent cells on ice, and transform cells immediately following thawing. After adding DNA, mix by tapping the tube gently. Do not mix cells by pipetting or vortexing.

Transformation Efficiency Calculation:
Transformation Efficiency (TE) is defined as the number of colony forming units (cfu) produced by transforming 1µg of plasmid into a given volume of competent cells.

TE = Colonies/µg/Dilution

Transform 1 µl of (10 pg/µl) pUC19 control plasmid into 50 µl of cells, add 950 µl of Recovery Medium. Dilute 10 µl of this in 990 µl of Recovery Medium and plate 50 µl. Count the colonies on the plate the next day. If you count 100 colonies, the TE is calculated as follows:

Colonies = 100
µg of DNA = 0.00001
Dilution = 50/1000 x 10/1000 = 0.0005
TE = 100/.00001/.0005 = 2.0×1010

Click the IG® Calculator to Find Your Transformation Efficiency

 

High-Efficiency Transformation Protocol:
Use this procedure to transform IG® C41(DE3) Electrocompetent Cells. Do not use these cells for chemical transformation.
 

1. DNA/Cell Mixture Preparation
1.1. Remove competent cells from the –80 °C freezer and thaw completely on wet ice (10–15 minutes). Place sterile electroporation cuvettes and microcentrifuge tubes on ice. Bring IG Recovery Medium to room temperature.
1.2. Aliquot 1–5 µl DNA (1 pg–100 ng) into chilled microcentrifuge tubes on ice. If using the pUC19 control, add 1 µl pUC19 DNA (10 pg/µl) to a chilled microcentrifuge tube.
1.3. Once the cells are thawed, gently add 25 µl of competent cells to each DNA tube while keeping the mixture on ice. Mix gently by tapping the tube 4–5 times.
Do not pipette up and down or vortex, as this may damage the cells and reduce transformation efficiency.
 

2. Electroporation
2.1. Pipette 26 µl of the cell/DNA mixture into a chilled electroporation cuvette, avoiding bubbles. Quickly flick the cuvette downward to ensure the mixture settles evenly across the bottom of the cuvette, then proceed with electroporation.

Standard electroporation settings for E. coli:
Voltage: 1.8 kV, Resistance: 200 Ω, Capacitance: 25 µF, Cuvette gap: 0.1 cm.

 

3. Cell Recovery
3.1. Immediately add 974 µl of room-temperature IG Recovery Medium (or another suitable medium) to the cuvette. Gently pipette up and down three times to resuspend the cells.
3.2. Transfer the entire mixture to a culture tube (17 mm × 100 mm) and incubate in a 37 °C shaking incubator at 210 rpm for 1 hour.
 

4. Cell Plating
4.1. Prepare pre-warmed selection plates during the recovery period. Plates should be equilibrated to 37 °C and free of condensation to prevent contamination and mixed colonies.
4.2. Dilute the recovered cells 10–100X, if necessary, to obtain well-isolated colonies. Plate 20–200 µl of cells onto pre-warmed LB agar plates containing the appropriate antibiotic(s). For the pUC19 control, plate 50 µl of a 100X diluted transformation onto an LB plate containing 100 µg/ml ampicillin. Spread the cells evenly using a sterile spreader or autoclaved ColiRoller™ plating beads.
4.3. Incubate the plates overnight (12–16 hours) at 37 °C.
 

References:
1. Walker JE & Miroux B. US6361966.
2. Miroux B, Walker JE. J Mol Biol. 1996 260:289-98.
3. Dumon-Seignovert L, Cariot G, Vuillard L.Protein Expr Purif. 2004 37:203-6.
4. Wagner S, et al. Proc Natl Acad Sci U S A. 2008. PMID: 18796603
5. Kwon et. al. Sci Rep. 2015 5:16076
6. Zhang et. al. Microb Cell Fact. 2015 14:142.
7. Bajzert et. al. BMC Vet Res. 2022 18(1):409.

 

Downloads

IG C41(DE3) Electrocompetent Cells Manual

IG C41(DE3) Electrocompetent Cells MSDS

Certificate of Origin – IG C41(DE3) Electrocompetent Cells

 

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200